trial · primary record
Trimethoprim-sulfamethoxazole (TMP/SMX)
Small Intestine Bacterial Overgrowth
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-12-02 |
| Primary endpoint | Conversion to Glucose Hydrogen Breath Test (GHBT) Negativity at Day 15 |
| Registry ID | NCT07451171 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:53.107Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07451171
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.